Enthusiasm key to rep's success
Rep profile
Rep profile
John Sampson
company
Schwarz Pharma
Title
Executive pharmaceutical representative and regional trainer
current home
Orlando, FL
Territory: Orlando and north and west suburbs.
Customers: Cardiologists, nephrologists, urologists, gastroenterologists, general physicians, internal medicine and OB/GYNs.
Awards: In 1991 and 1996, Sampson won the National Sales Award.
Sales techniques: "I give a balanced presentation and feel the representative and physician should come to an understanding about the products they sell. The physician needs to know why he or she should use my product. I need to know what a physician wants in pharmaceuticals. This brings me and the physician to an understanding of each others needs and allows us to reach an agreement about the products."
Sales philosophy: "I am enthusiastic about our products and believe in them 100 percent. I transfer that enthusiasm to the physician."
On mentors: "If you want to achieve what the average person does, you get a consensus. If you want to achieve what the top 10 percent does, you seek them out and find out what they do."
On motivation: "I always reflect upon how I could have done things better and improve on that next time. I also set realistically high goals to keep motivated and take small steps to achieve them."
The top three qualities a rep needs to succeed: "Be enthusiastic, maintain your principles and treat your job as though it were your own business."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
